AV-101

VistaGen fails phase 2 depression trial, sparking stock rout
Fierce Biotech
Thu, 11/14/19 - 10:36 am
VistaGen
AV-101
major depressive disorder
clinical trials
VistaGen’s AV-101 Snags Fast Track Designation, Other Drugmakers Move Ahead with Non-Opioid Pain Treatment Programs
BioSpace
Mon, 10/8/18 - 09:53 am
VistaGen
AV-101
FDA
fast track
neuropathic pain
BioWave
Virpax Pharmaceuticals